Investigation of the Effect of Abdominal Massage Applied to Palliative Care Patients on Constipation and Quality of Life
1 other identifier
interventional
52
1 country
2
Brief Summary
The problem of constipation plays a very important role among these symptoms that patients experience intensely and negatively affect their quality of life. Although constipation is not a disease, it is a condition that causes discomfort to the person and may develop due to idiopathic reasons, as well as depending on diet, exercise habits, medications used and various disease processes. It may also occur. Constipation is one of the most common symptoms in patients treated in palliative care, and its prevalence is thought to be approximately 30-90%. Constipation is the third most common problem in palliative care, after pain and loss of appetite. Although drug therapy is the first method that comes to mind in the treatment of constipation, as it is known, medical treatment has many side effects risks and long-term drug use causes health problems. It creates a high financial burden on the care system. The high side effects and costs of laxative drugs used in the management of constipation necessitate the use of non-pharmacological methods. Non-pharmacological methods used in the management of constipation generally include regular exercise, fluid intake, and increased consumption of fiber foods. One of them is the abdominal massage method. The number of studies on the effects of abdominal massage in the Palliative Care patient group, who frequently experience constipation, is very limited in the literature. For these reasons, the study was planned to examine the effect of abdominal massage applied to palliative care patients on constipation and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 19, 2022
CompletedFirst Posted
Study publicly available on registry
February 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedSeptember 13, 2023
September 1, 2023
6 months
December 19, 2022
September 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
To accept the hypothesis that the application of abdominal massage to palliative care patients has an effect on constipation.
Constipation Severity Scale (CSS) will be used to measure the effect of abdominal massage applied to the experimental group on constipation. There are 16 questions in the scale. The Constipation Severity Scale has three sub-dimensions: Stool Obstruction, Large Intestine Laziness, and Pain. The score that can be taken from the stool obstruction sub-dimension is 0-28, the score that can be taken from the large intestine laziness sub-dimension is between 0-29, and the score that can be taken from the pain sub-dimension is between 0-16. The lowest total score that can be obtained from the scale is 0, and the highest is 73. A high score on the scale indicates that the symptoms are serious.
1 weeks
To accept the hypothesis that the application of abdominal massage to palliative care patients has an impact on quality of life.
Constipation Quality of Life Scale, the scale developed to determine the effect of constipation on quality of life, consists of "worry/anxiety" (11 items), "physical discomfort" (4 items), "psychosocial discomfort" (8 items), "satisfaction" (5 items) subscales. consists of scales. The scale consists of 28 items in total. The highest score that can be obtained from the five-point Likert scale is 140, and the lowest score is 28. As the scores obtained from the scale increase, it is thought that the quality of life is negatively affected.
1 weeks
Study Arms (1)
Massage
EXPERIMENTALIn the experimental group, twice a day, in the morning and evening, and 30 minutes after the meal, for 15 minutes. Effusion, petrissage and vibration massage movements will be applied by the researcher for a certain period of time in accordance with the procedure (Abdominal Massage Application Directive). The application will continue for 7 days.
Interventions
* Experiment group twice a day in the morning and evening and 30 minutes after the feeding meal, for 15 minutes. For a period of time, effusion, petrissage, vibration massage movements will be applied by the researcher in accordance with the procedure (Abdominal Massage Application Directive). The application will continue for 7 days.- On the 3rd day (short term), 5th day (mid term) and 7th day (long term) to the massaged experimental group, the Constipation Severity Scale (CQS) and the Constipation Quality of Life Scale (QQQL) will be administered to determine the effect. * Day 7 Rome Ш Constipation Diagnostic Criteria (Annex: 2) will be applied again and the patient's constipation status will be evaluated for the last time. * Routine treatment and care practices in the clinic will continue.
Eligibility Criteria
You may qualify if:
- A first-degree relative or volunteer to participate in the research approved to participate in the research by
- years and over,
- A first-degree relative or volunteer to participate in the research approved to participate in the research by
- Having at least 2 or more of the Rome III constipation diagnostic criteria,
- Constipation Severity Scale score is 25 and above,
- No intestinal obstruction
- No radiotherapy or surgery was applied to the abdominal region until six weeks ago,
- Does not have diarrhea,
- Patients who do not have abdominal massage application restrictions.
You may not qualify if:
- Those who do not volunteer to participate in the research or who are not approved to participate in the research by their first-degree relatives,
- under the age of 18,
- Patients who do not receive inpatient treatment and care in the palliative care service.
- Those who do not volunteer to participate in the research or who are not approved to participate in the research by their first-degree relatives,
- Below 2 of the Rome III constipation diagnostic criteria
- Constipation Severity Scale score below 25 points
- Intestinal obstruction
- Radiotherapy or surgery was applied to the abdominal region up to six weeks ago,
- Having diarrhea
- Patients with abdominal massage application restrictions will be formed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sevil PAMUK CEBECİ
Eskişehir, Eskişehir, 26020, Turkey (Türkiye)
Eskişehir Şehir Hastanesi
Eskişehir, 26020, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sevil PAMUK CEBECİ, Asst.Prof.
sevil.pamukcebeci@ogu.edu.tr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst.Prof.Dr.
Study Record Dates
First Submitted
December 19, 2022
First Posted
February 24, 2023
Study Start
December 1, 2022
Primary Completion
May 30, 2023
Study Completion
June 30, 2023
Last Updated
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share